Sort
39,280 grants matching “leukemia”
Complexity, Cooperation and Community in Cancer
$2,087,357John Lowengrub · University Of California-Irvine · U54 · FY2021 · CA
Genomics Of Acute Myeloid Leukemia.
$2,084,756Timothy J Ley · Washington University · P01 · FY2019 · CA
Topology of Cancer Evolution and Heterogeneity
$2,081,527Raul Rabadan · Columbia University Health Sciences · U54 · FY2016 · CA
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
$2,080,518John E Wagner · University Of Minnesota · P01 · FY2025 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$2,080,062Michael A Caligiuri · Ohio State University · P01 · FY2010 · CA
Biology & Transplantation of the Human Stem Cell
$2,080,053Philip McGlave · University Of Minnesota · P01 · FY2008 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,079,438Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Targeted Sphingolipid Metabolism for Treatment of AML
$2,077,502Thomas P Loughran · University Of Virginia · P01 · FY2015 · CA
Engineered bone marrow niche to reconstitute T cell immunity
$2,076,253David T Scadden · Harvard University · U54 · FY2019 · CA
Hematopoietic Stem Cells for Transplantation
$2,075,973Saul J Sharkis · Johns Hopkins University · P01 · FY2012 · CA
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$2,075,838Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Hematopoietic Stem Cells for Transplantation
$2,075,614Saul J Sharkis · Johns Hopkins University · P01 · FY2011 · CA
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
$2,074,913Brenda Marie Sandmaier · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
$2,074,913Brenda Marie Sandmaier · Fred Hutchinson Cancer Center · P01 · FY2023 · CA
NK cells, their receptors and unrelated donor transplant
$2,074,355Jeffrey S Miller · University Of Minnesota · P01 · FY2014 · CA
Biology & Transplantation of the Human Stem Cell
$2,072,348Philip McGlave · University Of Minnesota · P01 · FY2006 · CA
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge
$2,071,892Brenda Marie Sandmaier · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Growth Factor Imaging and Photoimmunotherapy
$2,071,751Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Novel Therapeutic Strategies in Human Myeloid Leukemias
$2,071,388Dana-Farber Cancer Institute · P01 · FY2003 · CA
Acquisition of a High-Field Dual Source FTICR-MS for Pharmaceutical Research
$2,070,000Lingjun Li · University Of Wisconsin-Madison · S10 · FY2011 · RR
Translational Multimodality " Antibody" Therapy
$2,069,586University Of California Davis · P01 · FY2004 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,069,565Steven Mark Albelda · University Of Pennsylvania · P01 · FY2019 · CA
Administrative Core A
$2,069,128Benjamin Levine Ebert · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Biology & Transplantation of the Human Stem Cell
$2,065,942Philip McGlave · University Of Minnesota · P01 · FY2007 · CA
BIOLOGY AND GENETICS OF MARROW ALLOGRAFTS FOR LEUKEMIA
$2,065,351Sloan-Kettering Institute For Cancer Res · P01 · FY2000 · CA